Related Experiment Video
Updated: Jul 5, 2026
05:22
Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
Densiron intraocular tamponade: a case series
1The Eye Hospital, Launceston, Tasmania, Australia.
Clinical & Experimental Ophthalmology
|April 17, 2008
Summary
Densiron, a heavy silicone oil, shows promise for treating complex retinal detachments, particularly those with inferior proliferative vitreoretinopathy. This endotamponade agent demonstrated a 70% success rate and improved visual acuity in patients who previously failed surgery.
Area of Science:
- Ophthalmology
- Retinal Surgery
- Vitreoretinal Interface
Background:
- Complex retinal detachments, especially those with inferior proliferative vitreoretinopathy, present significant surgical challenges.
- Previous surgical interventions may fail, necessitating alternative treatment strategies.
Purpose of the Study:
- To evaluate the efficacy and safety of Densiron, a novel heavy silicone oil, as an endotamponade agent.
- To assess its utility in managing complex retinal detachments with inferior proliferative vitreoretinopathy.
Main Methods:
- A retrospective review of case notes was conducted.
- Ten eyes with recurrent retinal detachments involving inferior proliferative vitreoretinopathy, treated with Densiron, were analyzed.
Main Results:
- The overall success rate for long-term total retinal reattachment was 70%.
- Mean preoperative visual acuity improved significantly from logMAR 2.03 to logMAR 1.00 postoperatively (P = 0.001).
- Densiron was generally well-tolerated with a low incidence of side effects.
Conclusions:
- Densiron appears to be a safe and effective endotamponade agent for complex retinal detachments.
- It offers a viable option for patients with inferior proliferative vitreoretinopathy, particularly after surgical failure.
Related Concept Videos
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:14Increased Intracranial Pressure l: Introduction
Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...